VaramirStart free · no cardSign in
CMPX as of Oct 31 · 17:43 ET
CMPXNasdaqBiological Products, (No Diagnostic Substances)

Compass Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 7≥ implied
avg implied
±36.8%
avg realized
±4.6%
Feb 27 '25±52.2%▼−1.68%×0.03
May 8 '25±57.9%▲+1.14%×0.02
Aug 11 '25±32.7%▲+23.70%×0.72
Q3 FY25±13.1%▲+0.79%×0.06
Jan 6 '26±33.6%▼−1.60%×0.05
Q1 FY26±52.0%▼−2.81%×0.05
May 5 '26±16.1%▲+0.52%×0.03
Q2 FY26—▲+5.29%—
quarterimplied−60%0+60%realized×
Q2 FY26—▲+5.29%—
May '26±16.1%▲+0.52%×0.03
Q1 FY26±52.0%▼−2.81%×0.05
Jan '26±33.6%▼−1.60%×0.05
Q3 FY25±13.1%▲+0.79%×0.06
Aug '25±32.7%▲+23.70%×0.72
2 older reports
May '25±57.9%▲+1.14%×0.02
Feb '25±52.2%▼−1.68%×0.03
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

6disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding CMPXN-PORT · Aug 31 '26

Bear2 of 3

7 of 7recent reports where the move came in under the options implied rangeEarnings history
5 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CMPX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±33.5% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.